Biallelic variants in the RFC4 gene cause a rapidly progressive congenital myopathy with severe hypotonia and axial weakness
Language English Country England, Great Britain Media print-electronic
Document type Case Reports, Journal Article
PubMed
40327962
DOI
10.1016/j.nmd.2025.105366
PII: S0960-8966(25)00093-8
Knihovny.cz E-resources
- Keywords
- Cerebellar atrophy, Hearing loss, Morimoto-Ryu-Malicdan neuromuscular syndrome, Multisystemic disorders, Myopathy, RFC4,
- MeSH
- Child MeSH
- Phenotype MeSH
- Humans MeSH
- Myotonia Congenita * genetics physiopathology MeSH
- Child, Preschool MeSH
- Disease Progression MeSH
- Siblings MeSH
- Muscle Hypotonia * genetics physiopathology MeSH
- Muscle Weakness * genetics physiopathology MeSH
- Check Tag
- Child MeSH
- Humans MeSH
- Male MeSH
- Child, Preschool MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
The RFC4 gene has recently been linked to a multisystemic disorder Morimoto-Ryu-Malicdan neuromuscular syndrome, with myopathy being one of the key symptoms described in nine patients. We report the case of two brothers with a rapidly progressive congenital myopathy characterized by severe hypotonia and axial muscle weakness associated with previously unpublished biallelic variants in the RFC4 gene. Whole exome sequencing revealed biallelic variants NM_002916.5:c.1019_1020insCAAA and NM_002916.5:c.982_983insACT, corresponding to the protein-level changes p.(Gly341Lysfs*4) and p.(Thr328delinsAsnSer) in both brothers. This case expands the phenotypic spectrum of Morimoto-Ryu-Malicdan neuromuscular syndrome, highlighting severe early-onset axial muscle weakness, severe hypotonia, and preserved intellectual development. We also provide novel insights into the clinical progression and potential multidisciplinary interventions for patients with Morimoto-Ryu-Malicdan neuromuscular syndrome. Our findings highlight the importance of advanced genetic diagnostics and international collaboration in identifying rare neuromuscular diseases and improving the clinical management of affected patients.
References provided by Crossref.org